Skip to main content
SpringerLink
Log in

Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Purpose

We assessed therapeutic outcomes of reirradiation with helical tomotherapy (HT) for locoregional recurrent nasopharyngeal carcinoma (LRNPC) patients.

Methods and materials

Treatment outcomes were evaluated retrospectively in 17 consecutive LRNPC patients receiving HT between 2006 and 2012. Median age was 57 years and most patients (n = 13) were male. Simultaneous systemic therapy was applied in 5 patients. Initial treatment covered the gross tumor volume with a median dose of 70 Gy (60–81.6 Gy). Reirradiation was confined to the local relapse region with a median dose of 63 Gy (50–70.2 Gy), resulting in a median cumulative dose of 134 Gy (122–148.2 Gy). The median time interval between initial and subsequent treatment was 42 months (11–126).

Results

The median follow-up for the entire cohort was 23 and 35 months for survivors. Three patients (18 %) developed both local and distant recurrences and only one patient (6 %) suffered from isolated local recurrence. Two-year actuarial DFS and LC rates were 74 and 82 %, respectively. Two-year OS rate was 79 %. Acute and late grade 2 toxicities were observed in 8 patients (47 %). No patient experienced late grade ≥3 toxicity. Late toxicity included fibrosis of skin, hypoacusia, dysphagia, and xerostomia. Patients with higher Karnofsky performance status scores associated with a lower risk of mortality (HR 0.85, p = 0.015).

Conclusion

Reirradiation with HT in patients with LRNPC is feasible and yields encouraging results in terms of local control and overall survival with acceptable toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kasperts N, Slotman B, Leemans CR, Langendijk JA. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol. 2005;41:225–43.

    Article  CAS  PubMed  Google Scholar 

  2. Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck. 2008;30:281–8.

    Article  PubMed  Google Scholar 

  3. De Crevoisier R, Bourhis J, Domenge C, Wibault P, Koscielny S, Lusinchi A, et al. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol. 1998;16:3556–62.

    PubMed  Google Scholar 

  4. Duprez F, Madani I, Bonte K, Boterberg T, Vakaet L, Derie C, et al. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiother Oncol. 2009;93:563–9.

    Article  PubMed  Google Scholar 

  5. Hoebers F, Heemsbergen W, Moor S, et al. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity. Int J Radiat Oncol Biol Phys. 2011;81:e111–8.

    Article  PubMed  Google Scholar 

  6. Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:731–40.

    Article  PubMed  Google Scholar 

  7. Jeong S, Yoo EJ, Kim JY, Han CW, Kim KJ, Kay CS. Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy. Radiat Oncol J. 2013;31:206–15.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Stuschke M, Kaiser A, Abu-Jawad J, Pöttgen C, Levegrün S, Farr J. Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy. Radiat Oncol. 2013;8:93.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Lee TF, Fang FM, Chao PJ, Su TJ, Wang LK, Leung SW. Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma. Radiother Oncol. 2008;89:89–96.

    Article  PubMed  Google Scholar 

  10. Agnese D, Belgioia L, Bacigalupo A, Marcenaro M, Vecchio S, Agostinelli S, et al. Prolonged complete remission after induction chemotherapy followed by chemoradiation with tomotherapy in metastatic nasopharyngeal cancer. Anticancer Res. 2014;34(9):5075–8.

    PubMed  Google Scholar 

  11. Du L, Zhang XX, Ma L, Feng LC, Li F, Zhou GX, et al. Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes. Biomed Res Int. 2014;2014:1–11. Article ID 980767. doi:10.1155/2014/980767.

  12. Leung SW, Lee TF. Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience. Radiat Oncol. 2013;8:107.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.

    Article  CAS  PubMed  Google Scholar 

  14. Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG. Decision making in the management of recurrent head and neck cancer. Head Neck. 2014;36:144–51.

    Article  PubMed  Google Scholar 

  15. Duprez F, Berwouts D, Madani I, Bonte K, Boterberg T, De Gersem W, et al. High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity. Radiother Oncol. 2014;111:388–92.

    Article  PubMed  Google Scholar 

  16. Roeder F, Zwicker F, Saleh-Ebrahimi L, Timke C, Thieke C, Bischof M, et al. Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer. Radiat Oncol. 2011;6:22.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Teo PM, Kwan WH, Chan AT, Lee WY, King WW, Mok CO. How successful is high dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys. 1998;40:897–913.

    Article  CAS  PubMed  Google Scholar 

  18. Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, Wong CS, et al. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:1331–8.

    Article  CAS  PubMed  Google Scholar 

  19. Zheng XK, Ma J, Chen LH. Dosimetric and clinical results of three dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiother Oncol. 2005;75:197–203.

    Article  PubMed  Google Scholar 

  20. Jeong S, Yoo EJ, Kim JY, Han CW, Kim KJ, Kay CS. Re-irradiation of unresectable recurrent head and neck cancer: using helical tomotherapy as image-guided intensity-modulated radiotherapy. Radiat Oncol J. 2013;31(4):206–15.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Widesott L, Pierelli A, Fiorino C, Dell’oca I, Broggi S, Cattaneo GM, et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys. 2008;72:589–96.

    Article  PubMed  Google Scholar 

  22. Han F, Zhao C, Huang SM, Lu LX, Huang Y, Deng XW, et al. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol). 2012;24:569–76.

    Article  PubMed  Google Scholar 

  23. Mesía R, Pastor M, Grau JJ, del Barco E, SEOM. SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013. Clin Transl Oncol. 2013;15:1025–9.

    Article  PubMed  Google Scholar 

  24. Pastor Borgoñón M, Mesía Nin R, Cruz Hernández JJ, Isla Casado D, SEOM (Spanish Society for Medical Oncology). SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma. Clin Transl Oncol. 2010;12:749–52.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Dr. Ascary Velazquez for his contribution to this study.

Conflict of interest

The authors had no conflict of interest in this study.

Author information

Author notes

    Authors and Affiliations

    1. Department of Radiation Oncology, San Carlos University Hospital, Madrid, Spain

      F. Puebla

    2. Máster en Aplicaciones tecnológicas avanzadas en Oncología Radioterápica, Universidad de Murcia y Fundación Grupo IMO, Madrid, Spain

      F. Puebla, J. L. Lopez Guerra, J. M. Garcia Ramirez, R. Matute, I. Marrone, C. Miguez, D. Sevillano, A. Sanchez-Reyes & I. Azinovic

    3. Department of Radiation Oncology, Virgen del Rocío University Hospital, s/n. 41013, Manuel Siurot Avenue, Seville, Spain

      J. L. Lopez Guerra

    4. Department of Radiation Oncology, Instituto Madrileño de Oncología/Grupo IMO, Madrid, Spain

      J. M. Garcia Ramirez, R. Matute, I. Marrone & I. Azinovic

    5. Radiation Physics, Instituto Madrileño de Oncología/Grupo IMO, Madrid, Spain

      C. Miguez, D. Sevillano & A. Sanchez-Reyes

    6. Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, Paris, France

      E. Rivin del Campo

    7. Methodology Unit, Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla, Virgen del Rocío University Hospital, Seville, Spain

      J. M. Praena-Fernandez

    Authors
    1. F. Puebla
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. J. L. Lopez Guerra
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. J. M. Garcia Ramirez
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. R. Matute
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. I. Marrone
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. C. Miguez
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. D. Sevillano
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. A. Sanchez-Reyes
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. E. Rivin del Campo
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. J. M. Praena-Fernandez
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. I. Azinovic
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to J. L. Lopez Guerra.

    Additional information

    F. Puebla and J. L. Lopez Guerra contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Puebla, F., Lopez Guerra, J.L., Garcia Ramirez, J.M. et al. Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma. Clin Transl Oncol 17, 925–931 (2015). https://doi.org/10.1007/s12094-015-1328-5

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12094-015-1328-5

    Keywords

    Search

    Navigation